Get started
Author

Yoshiyuki Kenmotsu

ORCID: 0009-0001-3449-7276
Observed ORCID: 0009-0001-3449-7276
OpenAlex ID: A5042322338
Successful management of a patient with active Cushing’s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia
2020 · Akiko Yuno, Yoshiyuki Kenmotsu, et al. · Endocrine Journal · 19
PDF
Proposal for Managing Cancer‐Related Insomnia: A Systematic Literature Review of Associated Factors and a Narrative Review of Treatment
2024 · Yoshinori Saeki, Yukiyoshi Sumi, et al. · Cancer Medicine · 18
PDF
Tamoxifen-induced Lung Injury
2017 · Satoshi Etori, Ryoji Nakano, et al. · Internal Medicine · 15
PDF
Nedaplatin and irinotecan in patients with large-cell neuroendocrine carcinoma of the lung.
2012 · Yoshiyuki Kenmotsu, Fumihiro Oshita, et al. · PubMed · 14
Nedaplatin and irinotecan for patients with recurrent small cell lung cancer.
2012 · Miki Ohe, Fumihiro Oshita, et al. · PubMed · 3
[A Case of Pulmonary Pleomorphic Carcinoma in a Hemodialysis Patient Treated with Pembrolizumab].
2022 · Satoshi Etori, Yoshiyuki Kenmotsu, et al. · PubMed · 1
Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional Study
2026 · Hiroshi Yokouchi, Hiroshi Nishihara, et al. · ImmunoTargets and Therapy
Prognostic significance of VISTA expression in patients with malignant pleural mesothelioma treated with nivolumab: Results of a retrospective multi-institutional analysis (HOT1901).
2025 · Hiroshi Yokouchi, Hiroshi Nishihara, et al. · Journal of Clinical Oncology
A case of invasive pulmonary aspergillosis with a hemorrhagic duodenal ulcer
2017 · Satoshi Etori, Ryoji Nakano, et al. · 日本呼吸器学会誌(Web)
Works count: 9
Citation count: 70
H-index: 4
I10-index: 4
Year
Topic
Type